Innovation Pharmaceuticals Inc (IPIX)

[frrol]

Aspire is in the business of providing equity lines, and are compensated accordingly. They are not in the business of taking market risk. They sell what they "buy". Even their fee is in shares. They sell over time, and stay under contractual and regulatory holding limits, otherwise we'd see a Form 3.

So the IPIX share market faces steady selling as the company uses ("draws on") the Aspire line, even episodically. And there isn't much demand to absorb it recently. Being OTC, share buyers are primarily retail. And even retail sells when it wants to. All the time.